Materia Malta Operating has completed its first export of commercial medical cannabis from its EU GMP manufacturing site.
This represents the launch of Materia's own brand and manufactured products in Germany. The Company's German distribution subsidiary, Materia Deutschland GmbH, which took delivery of the shipment, has commenced sales to pharmacies, with a number of pre-orders already received.
Materia becomes one of the first Malta-based manufacturers of medical cannabis to export products for commercial sale in another country. Previous exports have only been approved for R&D or lab testing purposes.
"Our products are already helping patients in Malta improve their quality of life, and now we can support the needs of patients in Germany too," said Nick Pateras, Managing Director, Europe of Materia.
"We believe Malta will play an important role in the global cannabis supply chain, as it has done within the broader pharmaceuticals sector for decades. We are proud to be the company establishing new frontiers for Malta's and Europe's cannabis industry."